
Loading, please wait...

Loading, please wait...

The Food Safety and Standards Authority of India (FSSAI) recently initiated a strict enforcement action against a Gujarat manufacturer. This FSSAI Alkaline Water Ban followed a consumer complaint highlighting misbranding and the use of prohibited substances. Consequently, inspectors visited the Savli unit in Vadodara to investigate these grievances. They discovered severe violations, including visible black particles within the finished water products.
Laboratory tests later confirmed that the product contained fulvic acid. Notably, fulvic acid is not a permitted ingredient under current Indian food safety regulations. Furthermore, technical scrutiny revealed blackish-brown discolouration and sediment deposits. The manufacturer reportedly introduced these contaminants by adding black mineral substances. However, these minerals were not naturally present in the raw water source, marking a clear safety violation.
Medical professionals should note the potential risks associated with unapproved additives like fulvic acid. For instance, high concentrations of fulvic acid in drinking water may increase the risk of Kashin-Beck bone disease in selenium-deficient populations. Additionally, this substance might interfere with medications such as anticoagulants or thyroid hormones. Therefore, the consumption of unregulated alkaline water poses significant health concerns for patients.
Regulatory officials subsequently seized stocks worth approximately Rs 31.61 lakh from the company. Moreover, the FSSAI initiated formal legal proceedings under the Food Safety and Standards (FSS) Act, 2006. The inspection also highlighted missing ingredient declarations and contradictory labels between primary and secondary packaging. FSSAI remains committed to ensuring all food products in the market are safe, wholesome, and accurately labelled.
Q1: Why did FSSAI initiate an enforcement action against the Gujarat firm?
The FSSAI took action after finding misbranding, labelling violations, and the use of a non-permitted ingredient called fulvic acid. Inspectors also found black particles and sediments in the water during a post-licence inspection.
Q2: What is fulvic acid, and is it allowed in drinking water?
Fulvic acid is an organic compound often found in shilajit and soil. According to FSSAI regulations, it is not a permitted additive for packaged drinking or alkaline water in India.
Q3: What are the health implications of drinking contaminated alkaline water?
Consuming water with unapproved minerals and particles can lead to gastrointestinal distress or allergic reactions. Specifically, fulvic acid may interact with various medications and is linked to bone disease in certain conditions.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


FSSAI seizes Rs 31.61 lakh of alkaline water in Gujarat due to banned fulvic acid, black particles, and labelling violations. Essential news for health expe...
5 months ago

Novel diimide and hydrazone scaffolds, particularly compound #C4, synergistically reactivate latent HIV-1 when combined with JQ1 or PKC activators. Demonstrating donor-matched proviral transcription ex vivo and non-canonical signaling, these findings advance shock and kill strategies toward reservoir eradication.
Today

A cross-sectional study reveals that maternal RSV vaccination coverage reached only 43.7% in Argentina, with maternal vaccine knowledge being the sole independent predictor of uptake. Clinicians play a crucial role in eliminating informational and structural barriers to optimize infant health.
Today

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Yesterday

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Yesterday

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Yesterday